Atul Kumar (chemist)
Atul Kumar is a synthetic organic chemist, Professor/Sr. Principal Scientist at Academy of Scientific and Innovative Research (AcSIR)[1] and the Central Drug Research Institute (CSIR-CDRI)[2] at Lucknow, India and a Dean at National Institute of Pharmaceutical Education and Research, Raebareli.[3]
Academic work
Kumar has about 24 years experience in drug design, medicinal chemistry and Green Chemistry[4]
Dr.Kumar's major contributions are invention of Anti-osteoporosis Drug candidate CDRI-99/373 (CENTHANK), which is an currently in phase 1 clinical trial and NCE Anti-cancer Compound CDRI-S-007-1235 is currently in Pre-clinical stage.[5][6][7]
References
- ^ "AcSIR – Academy of Scientific & Innovative Research – Faculty List". acsir.res.in. Retrieved 24 September 2017. Search "Atul Kumar"
- ^ "Dr. Atul Kumar". www.cdri.res.in. CDRI. Archived from the original on 1 June 2018. Retrieved 24 September 2017.
- ^ "Administrative Team". niperraebareli.edu.in. National Institute of Pharmaceutical Education and Research, Raebareli. Retrieved 24 September 2017.
- ^ "Official website at CSIR". Archived from the original on 4 November 2014. Retrieved 4 November 2014.
- ^ cosmic. "CDRI | Home". www.cdri.res.in. Archived from the original on 23 September 2017. Retrieved 2 October 2017.
- ^ cosmic. "CDRI | Home". www.cdri.res.in. Archived from the original on 23 September 2017. Retrieved 2 October 2017.
- ^ Chakravarti, Bandana; Akhtar, Tahseen; Rai, Byanju; Yadav, Manisha; Siddiqui, Jawed Akhtar; Dwivedi, Shailendra Kumar Dhar; Thakur, Ravi; Singh, Anup Kumar; Singh, Abhishek Kumar (2014). "Thioaryl Naphthylmethanone Oxime Ether Analogs as Novel Anticancer Agents". Journal of Medicinal Chemistry. 57 (19): 8010–8025. doi:10.1021/jm500873e. PMID 25198997.
External links
  | This article about an Indian scientist is a stub. You can help Wikipedia by expanding it. |